| 000 | 01574cam a2200349 i 4500 | ||
|---|---|---|---|
| 001 | on1311312741 | ||
| 003 | OCoLC | ||
| 005 | 20240726104851.0 | ||
| 008 | 220416s2021 ii o 000 0 eng d | ||
| 040 |
_aEBLCP _beng _erda _epn _cEBLCP _dYDX _dOCLCQ _dOCLCF _dOCLCQ _dNT |
||
| 020 |
_a9354658369 _q((electronic)l(electronic)ctronic) |
||
| 020 |
_a9789354658365 _q((electronic)l(electronic)ctronic) |
||
| 050 | 0 | 4 |
_aRM666 _b.A436 2021 |
| 049 | _aMAIN | ||
| 100 | 1 |
_aGoyal, Vinay. _e1 |
|
| 245 | 1 | 0 | _aAmantadine in Parkinson's Disease. |
| 300 | _a1 online resource (60 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_adata file _2rda |
||
| 504 | _a2 | ||
| 505 | 0 | 0 |
_aCover -- _tTitle -- _tContents -- _tChapter 1 Clinical Signs and Symptoms of Parkinson's Disease -- _tChapter 2 Parkinson's Disease:Pathophysiology and Diagnosis -- _tChapter 3 Role of Amantadine in Parkinson's Disease -- _tChapter 4 Clinical Efficacy and Safety of Amantadine -- _tChapter 5 Amantadine: Dosage, Adverse Effects, and Drug-Drug Interactions -- _tIndex |
| 530 |
_a2 _ub |
||
| 650 | 0 | _aAmantadine. | |
| 650 | 0 | _aParkinson's disease. | |
| 655 | 1 | _aElectronic Books. | |
| 856 | 4 | 0 |
_zClick to access digital title | log in using your CIU ID number and my.ciu.edu password. _uhttpss://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3219295&site=eds-live&custid=s3260518 |
| 942 |
_cOB _D _eEB _hRM. _m2021 _QOL _R _x _8NFIC _2LOC |
||
| 994 |
_a92 _bNT |
||
| 999 |
_c81056 _d81056 |
||
| 902 |
_a1 _bCynthia Snell _c1 _dCynthia Snell |
||